Graypoint LLC Novartis Ag Transaction History

Graypoint LLC

$1.71 Billion
Q2 2025

A detailed history of Graypoint LLC transactions in Novartis Ag stock. As of the latest transaction made, Graypoint LLC holds 2,662 shares of NVS stock, worth $350,186. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,662

Previous 2,968 10.31%

Holding current value

$350,186

Previous $330,000 2.42%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$101.96 - $121.01 $31,199 - $37,029	-306 Reduced 10.31%	2,662 $322,000
Q1 2025 May 02, 2025	SELL	$97.14 - $115.57 $37,787 - $44,956	-389 Reduced 11.59%	2,968 $330,000
Q4 2024 Jan 10, 2025	SELL	$96.78 - $117.18 $37,163 - $44,997	-384 Reduced 10.26%	3,357 $326,000
Q3 2024 Oct 31, 2024	SELL	$106.13 - $120.89 $1,910 - $2,176	-18 Reduced 0.48%	3,741 $430,000
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $176,716 - $204,969	-1,909 Reduced 33.68%	3,759 $400,000

Q1 2024 May 02, 2024	SELL	$95.27 - $108.47 $3,906 - $4,447	-41 Reduced 0.72%	5,668 $548,000
Q4 2023 Jan 29, 2024	SELL	$92.27 - $101.54 $121,611 - $133,829	-1,318 Reduced 18.76%	5,709 $576,000
Q3 2023 Oct 26, 2023	SELL	$94.73 - $105.13 $24,156 - $26,808	-255 Reduced 3.5%	7,027 $715,000
Q2 2023 Jul 21, 2023	SELL	$92.52 - $104.91 $55,974 - $63,470	-605 Reduced 7.67%	7,282 $734,000
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $127,967 - $148,403	-1,599 Reduced 16.86%	7,887 $725,000
Q4 2022 Jan 31, 2023	SELL	$75.55 - $92.52 $8,763 - $10,732	-116 Reduced 1.21%	9,486 $860,000
Q3 2022 Oct 31, 2022	BUY	$74.61 - $87.26 $2,089 - $2,443	28 Added 0.29%	9,602 $730,000
Q2 2022 Aug 01, 2022	SELL	$80.52 - $93.75 $10,628 - $12,375	-132 Reduced 1.36%	9,574 $809,000
Q1 2022 Apr 19, 2022	SELL	$80.11 - $90.62 $3,604 - $4,077	-45 Reduced 0.46%	9,706 $852,000
Q4 2021 Jan 31, 2022	SELL	$79.7 - $88.13 $29,409 - $32,519	-369 Reduced 3.65%	9,751 $853,000
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $16,110 - $18,742	197 Added 1.99%	10,120 $828,000
Q2 2021 Aug 04, 2021	SELL	$85.24 - $94.15 $52,593 - $58,090	-617 Reduced 5.85%	9,923 $905,000
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $86,172 - $101,621	-1,032 Reduced 8.92%	10,540 $901,000
Q4 2020 Feb 05, 2021	SELL	$78.07 - $94.43 $164,415 - $198,869	-2,106 Reduced 15.4%	11,572 $1.09 Million
Q3 2020 Nov 02, 2020	SELL	$82.14 - $91.0 $185,882 - $205,933	-2,263 Reduced 14.2%	13,678 $1.19 Million
Q2 2020 Jul 30, 2020	BUY	$80.93 - $91.1 $88,699 - $99,845	1,096 Added 7.38%	15,941 $1.39 Million
Q1 2020 Apr 30, 2020	BUY	$70.67 - $99.01 $1.05 Million - $1.47 Million	14,845 New	14,845 $1.22 Million

Others Institutions Holding NVS

# of Institutions

1,600

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account